Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nachbagauer

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Mbio|January 23, 2020
Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in AdultsPhilip Meade, Guillermina Kuan, Shirin Strohmeier, et al.
Mbio|October 6, 2016
Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent MannerCaitlin E Mullarkey, Mark J Bailey, Diana A Golubeva, et al.
NPJ Vaccines|December 22, 2017
A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studiesRaffael Nachbagauer, Wen-Chun Liu, Angela Choi, et al.
Journal of Virology|June 15, 2018
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 ChallengeRaffael Nachbagauer, David Shore, Hua Yang, et al.
The Journal of Experimental Medicine|December 16, 2020
CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell responseYisi Lu, Roy Jiang, Alec W Freyn, et al.
Vaccine|May 12, 2020
Antibody responses to influenza A(H1N1)pdm infectionSteph Wraith, Raffael Nachbagauer, Angel Balmaseda, et al.
Nature Communications|June 19, 2023
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysisIvan T Lee, Raffael Nachbagauer, David Ensz, et al.
Vaccines|November 30, 2018
Erratum: Sunwoo, S.-Y. et al. A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines 2018, 6(3), 64Sun-Young Sunwoo, Michael Schotsaert, Igor Morozov, et al.
Vaccines|September 19, 2018
A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal AntibodiesSun-Young Sunwoo, Michael Schotsaert, Igor Morozov, et al.
The Journal of Clinical Investigation|September 7, 2018
Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominanceSean T H Liu, Mohammad Amin Behzadi, Weina Sun, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Mbio|January 23, 2020
Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in AdultsPhilip Meade, Guillermina Kuan, Shirin Strohmeier, et al.
Mbio|October 6, 2016
Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent MannerCaitlin E Mullarkey, Mark J Bailey, Diana A Golubeva, et al.
NPJ Vaccines|December 22, 2017
A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studiesRaffael Nachbagauer, Wen-Chun Liu, Angela Choi, et al.
Journal of Virology|June 15, 2018
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 ChallengeRaffael Nachbagauer, David Shore, Hua Yang, et al.
The Journal of Experimental Medicine|December 16, 2020
CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell responseYisi Lu, Roy Jiang, Alec W Freyn, et al.
Vaccine|May 12, 2020
Antibody responses to influenza A(H1N1)pdm infectionSteph Wraith, Raffael Nachbagauer, Angel Balmaseda, et al.
Nature Communications|June 19, 2023
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysisIvan T Lee, Raffael Nachbagauer, David Ensz, et al.
Vaccines|November 30, 2018
Erratum: Sunwoo, S.-Y. et al. A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines 2018, 6(3), 64Sun-Young Sunwoo, Michael Schotsaert, Igor Morozov, et al.
Vaccines|September 19, 2018
A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal AntibodiesSun-Young Sunwoo, Michael Schotsaert, Igor Morozov, et al.
The Journal of Clinical Investigation|September 7, 2018
Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominanceSean T H Liu, Mohammad Amin Behzadi, Weina Sun, et al.
Pageof 11